250 related articles for article (PubMed ID: 23886132)
1. MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors.
Ashkavandi ZJ; Najvani AD; Tadbir AA; Pardis S; Ranjbar MA; Ashraf MJ
Asian Pac J Cancer Prev; 2013; 14(6):3479-82. PubMed ID: 23886132
[TBL] [Abstract][Full Text] [Related]
2. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
[TBL] [Abstract][Full Text] [Related]
4. Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors.
Tadbir AA; Pardis S; Ashkavandi ZJ; Najvani AD; Ashraf MJ; Taheri A; Zadeh MA; Sardari Y
Asian Pac J Cancer Prev; 2012; 13(10):5155-9. PubMed ID: 23244127
[TBL] [Abstract][Full Text] [Related]
5. A microRNA signature for the differential diagnosis of salivary gland tumors.
Denaro M; Navari E; Ugolini C; Seccia V; Donati V; Casani AP; Basolo F
PLoS One; 2019; 14(1):e0210968. PubMed ID: 30682201
[TBL] [Abstract][Full Text] [Related]
6. Human α-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.
Winter J; Pantelis A; Kraus D; Reckenbeil J; Reich R; Jepsen S; Fischer HP; Allam JP; Novak N; Wenghoefer M
BMC Cancer; 2012 Oct; 12():465. PubMed ID: 23050799
[TBL] [Abstract][Full Text] [Related]
7. LEF-1: Diagnostic utility in distinguishing basaloid neoplasms of the salivary gland.
Schmitt AC; Griffith CC; Cohen C; Siddiqui MT
Diagn Cytopathol; 2017 Dec; 45(12):1078-1083. PubMed ID: 28972308
[TBL] [Abstract][Full Text] [Related]
8. MCM3 proliferative index is worthier over Ki-67 in the characterization of salivary gland tumors.
Raja R; Shetty DC; Chandrakanta ; Juneja S; Tandon A; Gulati N
Indian J Pathol Microbiol; 2021; 64(1):22-27. PubMed ID: 33433405
[TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of GLUT-1 and angiogenic index in pleomorphic adenomas, adenoid cystic carcinomas, and mucoepidermoid carcinomas of the salivary glands.
de Souza LB; de Oliveira LC; Nonaka CFW; Lopes MLDS; Pinto LP; Queiroz LMG
Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2549-2556. PubMed ID: 28299426
[TBL] [Abstract][Full Text] [Related]
10. Quantitative immunohistochemical fingerprinting of adhesion/growth-regulatory galectins in salivary gland tumours: divergent profiles with diagnostic potential.
Remmelink M; de Leval L; Decaestecker C; Duray A; Crompot E; Sirtaine N; André S; Kaltner H; Leroy X; Gabius HJ; Saussez S
Histopathology; 2011 Mar; 58(4):543-56. PubMed ID: 21410745
[TBL] [Abstract][Full Text] [Related]
11. Benign, malignant salivary gland tumors: comparison of immunohistochemical expression of e-cadherin.
Prabhu S; Kaveri H; Rekha K
Oral Oncol; 2009 Jul; 45(7):594-9. PubMed ID: 18955011
[TBL] [Abstract][Full Text] [Related]
12. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
Meer S; Altini M
Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
[TBL] [Abstract][Full Text] [Related]
13. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of cyclooxygenase-2 and cyclin D1 in salivary gland tumors.
Tenório JDR; da Silva LP; Xavier MGA; Santana T; do Nascimento GJF; Sobral APV
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2341-2347. PubMed ID: 30003391
[TBL] [Abstract][Full Text] [Related]
15. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
[TBL] [Abstract][Full Text] [Related]
16. PLAG1: An Immunohistochemical Marker with Limited Utility in Separating Pleomorphic Adenoma from Other Basaloid Salivary Gland Tumors.
Avadhani V; Cohen C; Siddiqui MT
Acta Cytol; 2016; 60(3):240-5. PubMed ID: 27463119
[TBL] [Abstract][Full Text] [Related]
17. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.
Toper MH; Sarioglu S
Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Detection of Proliferative Marker Ki-67 in Benign and Malignant Salivary Gland Tumors.
Bussari S; Ganvir SM; Sarode M; Jeergal PA; Deshmukh A; Srivastava H
J Contemp Dent Pract; 2018 Apr; 19(4):375-383. PubMed ID: 29728539
[No Abstract] [Full Text] [Related]
19. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP
Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of the expression of fatty acid synthase and Ki-67 in salivary gland tumors.
do Prado RF; da Silva Machado AL; Colombo CE; Carvalho YR
J Oral Pathol Med; 2011 Jul; 40(6):467-75. PubMed ID: 21385214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
